慢乙肝-话题@MedSci

#慢乙肝#

3篇内容 | 3244人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2249577, encodeId=7bf522495e761, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】有肝癌家族史的HBeAg阳性慢乙肝患者经多次聚乙二醇干扰素α联合治疗获HBeAg和HBsAg清除, objectType=article, longId=859879, objectId=80198598e9de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250122/1737543636981_8538692.jpg, objectUrl=/article/show_article.do?id=80198598e9de, replyNumber=0, likeNumber=4, createdTime=19小时前, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=80198598e9de, moduleTitle=【愈见乙肝2024】有肝癌家族史的HBeAg阳性慢乙肝患者经多次聚乙二醇干扰素α联合治疗获HBeAg和HBsAg清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80198598e9de)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2249442, encodeId=619e2249442ed, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】再添新证据：抗-HBc水平联合HBsAg可预测HBsAg清除, objectType=article, longId=859723, objectId=23d7859e23ec, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736847778037_8538692.png, objectUrl=/article/show_article.do?id=23d7859e23ec, replyNumber=0, likeNumber=5, createdTime=2025-01-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=23d7859e23ec, moduleTitle=【期刊导读】再添新证据：抗-HBc水平联合HBsAg可预测HBsAg清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23d7859e23ec)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2249336, encodeId=4b482249336bf, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】慢乙肝患者越早开始抗病毒治疗，肝癌发生风险越低, objectType=article, longId=859342, objectId=61e285934269, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=61e285934269, replyNumber=0, likeNumber=7, createdTime=2025-01-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=61e285934269, moduleTitle=【期刊导读】慢乙肝患者越早开始抗病毒治疗，肝癌发生风险越低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61e285934269)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2249100, encodeId=4c02224910087, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】HBsAg低水平的慢乙肝患者接受聚乙二醇干扰素α-2b短期治疗可获得高HBsAg清除率, objectType=article, longId=859194, objectId=0e8385919421, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736847778037_8538692.png, objectUrl=/article/show_article.do?id=0e8385919421, replyNumber=0, likeNumber=7, createdTime=2025-01-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=0e8385919421, moduleTitle=【期刊导读】HBsAg低水平的慢乙肝患者接受聚乙二醇干扰素α-2b短期治疗可获得高HBsAg清除率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e8385919421)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2248654, encodeId=23002248654b9, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】HBsAg清除、HBsAb水平较低时停药发生HBsAg复阳，短期再治疗获HBsAg血清学转换且HBsAb高, objectType=article, longId=859069, objectId=64ce859069ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736847778037_8538692.png, objectUrl=/article/show_article.do?id=64ce859069ad, replyNumber=0, likeNumber=5, createdTime=2025-01-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=64ce859069ad, moduleTitle=【愈见乙肝2024】HBsAg清除、HBsAb水平较低时停药发生HBsAg复阳，短期再治疗获HBsAg血清学转换且HBsAb高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64ce859069ad)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2248282, encodeId=6d3f2248282ff, content=<a href='/topic/show?id=aa791400831' target=_blank style='color:#2F92EE;'>#pegIFNα#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】新发现：血脂异常可能影响PegIFNα治疗慢乙肝患者的疗效, objectType=article, longId=858720, objectId=a7cb858e2081, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=a7cb858e2081, replyNumber=0, likeNumber=8, createdTime=2025-01-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=a7cb858e2081, moduleTitle=【期刊导读】新发现：血脂异常可能影响PegIFNα治疗慢乙肝患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7cb858e2081)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2247546, encodeId=58eb224e546b7, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】荟萃分析：加用聚乙二醇干扰素α治疗可显著提高核苷经治慢乙肝患者的HBsAg清除率及血清学转换率, objectType=article, longId=858234, objectId=f8a885823410, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=f8a885823410, replyNumber=0, likeNumber=12, createdTime=2025-01-11, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=f8a885823410, moduleTitle=【期刊导读】荟萃分析：加用聚乙二醇干扰素α治疗可显著提高核苷经治慢乙肝患者的HBsAg清除率及血清学转换率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8a885823410)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2247444, encodeId=aa34224e444ff, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】HBsAg高水平的核苷经治慢乙肝患者经间歇治疗策略获持久的HBsAg血清学转换, objectType=article, longId=857950, objectId=252c85e950a3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401030/1730265935847_8538692.jpg, objectUrl=/article/show_article.do?id=252c85e950a3, replyNumber=0, likeNumber=13, createdTime=2025-01-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=252c85e950a3, moduleTitle=【愈见乙肝2024】HBsAg高水平的核苷经治慢乙肝患者经间歇治疗策略获持久的HBsAg血清学转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=252c85e950a3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2247315, encodeId=67a5224e315e7, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】党双锁教授团队：巩固治疗< 12周和HBsAb消失是HBsAg清除后复发的高危因素, objectType=article, longId=857798, objectId=f80b85e79864, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240723/1721699880262_92910.jpg, objectUrl=/article/show_article.do?id=f80b85e79864, replyNumber=0, likeNumber=12, createdTime=2025-01-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=f80b85e79864, moduleTitle=【期刊导读】党双锁教授团队：巩固治疗< 12周和HBsAb消失是HBsAg清除后复发的高危因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f80b85e79864)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2245730, encodeId=d2e72245e3013, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=59ad2914473' target=_blank style='color:#2F92EE;'>#免疫耐受期#</a>, objectTitle=【会议撷萃】耿嘉蔚教授：慢乙肝免疫耐受期诊疗进展及临床研究, objectType=article, longId=857033, objectId=b7dd85e03310, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=b7dd85e03310, replyNumber=0, likeNumber=29, createdTime=2024-12-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=b7dd85e03310, moduleTitle=【会议撷萃】耿嘉蔚教授：慢乙肝免疫耐受期诊疗进展及临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7dd85e03310)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2245312, encodeId=1d1d224531299, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【会议撷萃】王福生院士：儿童慢乙肝抗病毒治疗和临床治愈, objectType=article, longId=857032, objectId=e52c85e032af, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240520/1716184707156_5579292.jpg, objectUrl=/article/show_article.do?id=e52c85e032af, replyNumber=0, likeNumber=16, createdTime=2024-12-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=e52c85e032af, moduleTitle=【会议撷萃】王福生院士：儿童慢乙肝抗病毒治疗和临床治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e52c85e032af)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2245071, encodeId=5b1322450e1e4, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】有肝硬化和肝癌家族史的核苷经治慢乙肝母子经基于聚乙二醇干扰素α的治疗同获HBsAg清除, objectType=article, longId=857031, objectId=b7e985e03145, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=b7e985e03145, replyNumber=0, likeNumber=26, createdTime=2024-12-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=b7e985e03145, moduleTitle=【愈见乙肝2024】有肝硬化和肝癌家族史的核苷经治慢乙肝母子经基于聚乙二醇干扰素α的治疗同获HBsAg清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7e985e03145)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2244678, encodeId=aeb422446e8c5, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【会议撷萃】窦晓光教授：慢性乙型肝炎临床治愈优势人群, objectType=article, longId=856349, objectId=fec785634959, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719481658993_92910.png, objectUrl=/article/show_article.do?id=fec785634959, replyNumber=0, likeNumber=23, createdTime=2024-12-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=fec785634959, moduleTitle=【会议撷萃】窦晓光教授：慢性乙型肝炎临床治愈优势人群, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fec785634959)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2244047, encodeId=02d8224404e8b, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】HBsAg清除后复阳的慢乙肝患者经联合抗病毒治疗短期内获临床治愈, objectType=article, longId=856210, objectId=e67d8562102a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=e67d8562102a, replyNumber=0, likeNumber=21, createdTime=2024-12-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=e67d8562102a, moduleTitle=【愈见乙肝2024】HBsAg清除后复阳的慢乙肝患者经联合抗病毒治疗短期内获临床治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e67d8562102a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243638, encodeId=1fdd22436387c, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【AASLD2024速递】50岁前获得HBsAg清除的无肝硬化慢乙肝患者预后更好, objectType=article, longId=856068, objectId=ebb3856068d6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240514/1715679836336_5579292.jpg, objectUrl=/article/show_article.do?id=ebb3856068d6, replyNumber=0, likeNumber=25, createdTime=2024-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=ebb3856068d6, moduleTitle=【AASLD2024速递】50岁前获得HBsAg清除的无肝硬化慢乙肝患者预后更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebb3856068d6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243485, encodeId=40a32243485db, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=【AASLD2024速递】核苷经治停药后复发的慢乙肝患者接受聚乙二醇干扰素α治疗后的应答率优于初治患者, objectType=article, longId=855904, objectId=c1d5855904b0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401030/1730265935847_8538692.jpg, objectUrl=/article/show_article.do?id=c1d5855904b0, replyNumber=0, likeNumber=20, createdTime=2024-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=c1d5855904b0, moduleTitle=【AASLD2024速递】核苷经治停药后复发的慢乙肝患者接受聚乙二醇干扰素α治疗后的应答率优于初治患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1d5855904b0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243514, encodeId=749e2243514a5, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=【AASLD 2024速递】目前血清HBV标志物不能很好反映初治HBeAg阴性慢乙肝患者肝内HBV复制活性, objectType=article, longId=851240, objectId=a0db8512400d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=a0db8512400d, replyNumber=0, likeNumber=22, createdTime=2024-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=a0db8512400d, moduleTitle=【AASLD 2024速递】目前血清HBV标志物不能很好反映初治HBeAg阴性慢乙肝患者肝内HBV复制活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0db8512400d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243275, encodeId=119d22432e550, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=3f8b8503cb' target=_blank style='color:#2F92EE;'>#HBcrAg#</a>, objectTitle=【AASLD2024速递】慢乙肝临床治愈持久性相关因素探索：循环CCR7(LO)PD-1(HI)滤泡辅助T细胞和HBcrAg水平, objectType=article, longId=851389, objectId=fd3985138939, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240520/1716173655527_5579292.jpg, objectUrl=/article/show_article.do?id=fd3985138939, replyNumber=0, likeNumber=22, createdTime=2024-12-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=fd3985138939, moduleTitle=【AASLD2024速递】慢乙肝临床治愈持久性相关因素探索：循环CCR7(LO)PD-1(HI)滤泡辅助T细胞和HBcrAg水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd3985138939)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243278, encodeId=8c1922432e863, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=774112250937' target=_blank style='color:#2F92EE;'>#HBV DNA#</a> <a href='/topic/show?id=1e4b122510f6' target=_blank style='color:#2F92EE;'>#HBV RNA#</a>, objectTitle=【AASLD2024速递】临床治愈患者的肝内整合HBV DNA和转录水平极低, objectType=article, longId=855534, objectId=32618555349d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241120/1732096450891_8538692.jpg, objectUrl=/article/show_article.do?id=32618555349d, replyNumber=0, likeNumber=18, createdTime=2024-12-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=32618555349d, moduleTitle=【AASLD2024速递】临床治愈患者的肝内整合HBV DNA和转录水平极低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32618555349d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2242284, encodeId=0e8a2242284dc, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】高灵敏HBcrAg检测或可有效预测HBeAg阴性慢乙肝患者的治疗疗效和疾病进展, objectType=article, longId=855247, objectId=73d685524ef5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719545882221_8538692.jpg, objectUrl=/article/show_article.do?id=73d685524ef5, replyNumber=0, likeNumber=25, createdTime=2024-12-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=73d685524ef5, moduleTitle=【AASLD2024速递】高灵敏HBcrAg检测或可有效预测HBeAg阴性慢乙肝患者的治疗疗效和疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73d685524ef5)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯话题小助手

慢乙肝

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#聚乙二醇干扰素α# #慢乙肝#

【愈见乙肝2024】有肝癌家族史的HBeAg阳性慢乙肝患者经多次聚乙二醇干扰素α联合治疗获HBeAg和HBsAg清除

19小时前发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#聚乙二醇干扰素α# #慢乙肝#

【期刊导读】再添新证据：抗-HBc水平联合HBsAg可预测HBsAg清除

2025-01-24发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#抗病毒治疗# #慢乙肝#

【期刊导读】慢乙肝患者越早开始抗病毒治疗，肝癌发生风险越低

2025-01-23发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#聚乙二醇干扰素α# #慢乙肝#

【期刊导读】HBsAg低水平的慢乙肝患者接受聚乙二醇干扰素α-2b短期治疗可获得高HBsAg清除率

2025-01-21发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2024】HBsAg清除、HBsAb水平较低时停药发生HBsAg复阳，短期再治疗获HBsAg血清学转换且HBsAb高

2025-01-18发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#pegIFNα# #慢乙肝#

【期刊导读】新发现：血脂异常可能影响PegIFNα治疗慢乙肝患者的疗效

2025-01-16发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#聚乙二醇干扰素α# #慢乙肝#

【期刊导读】荟萃分析：加用聚乙二醇干扰素α治疗可显著提高核苷经治慢乙肝患者的HBsAg清除率及血清学转换率

2025-01-11发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2024】HBsAg高水平的核苷经治慢乙肝患者经间歇治疗策略获持久的HBsAg血清学转换

2025-01-10发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】党双锁教授团队：巩固治疗< 12周和HBsAb消失是HBsAg清除后复发的高危因素

2025-01-09发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #免疫耐受期#

【会议撷萃】耿嘉蔚教授：慢乙肝免疫耐受期诊疗进展及临床研究

2024-12-31发表于陕西省

梅斯管理员 (审核中...)